AHSCX

Alger Health Sciences C
NasdaqUSDETF / FUND DELAYED
Last price
17.59
▼ 0.19 (1.07%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
17.59
Prev close
17.78
Day high
—
Day low
—
Volume
—
Market cap
—
P/E (TTM)
41.31
52W range
12.38 – 18.33

Day trading desk

Current session · delayed
Gap from prior close
-1.07%
Prior close 17.78
VWAP
—
—
Relative volume
—
—
Session range
—
17.59 – 17.59
Position in range
—
—
ATR (14D)
0.19
1.10% of price
Prior day high
17.78
PDH
Prior day low
17.78
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Shares traded

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-3.03% -4.9%
1M
+0.23% -1.2%
3M
+8.31% +4.9%
6M
+28.77% +13.8%
YTD
+26.00% +12.0%
1Y
+41.17% +25.4%
3Y
+49.32% -32.6%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Top holdings

9 shown · by weight
SymbolNameWeight
MRK Merck & Co Inc 4.17%
WELL Welltower Inc 4.12%
JNJ Johnson & Johnson 4.06%
TMO Thermo Fisher Scientific Inc 4.00%
BRKR Bruker Corp 3.98%
ILMN Illumina Inc 3.95%
CVS CVS Health Corp 3.69%
UNH UnitedHealth Group Inc 3.61%
TEVA Teva Pharmaceutical Industries Ltd ADR 3.53%

Sector exposure

Fund weightings
Healthcare
92.24%
Real estate
5.87%
Basic materials
1.89%

Fund profile

As reported
Fund familyAlger
CategoryHealth
Legal type—
Expense ratio1.96%
Turnover—
Total net assets—

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on AHSCX open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—

Valuation & profitability ratios

Account required
Trailing P/E41.31
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Options analytics

Account required
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Analyst targets & ownership

Account required
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
18.04
-2.49% from price
SMA 20
17.88
-1.61% from price
SMA 50
17.69
-0.55% from price
SMA 100
16.34
+7.64% from price
SMA 200
15.15
+16.11% from price
EMA 12
17.93
-1.89% from price
EMA 26
17.84
-1.41% from price
EMA 50
17.48
+0.63% from price
RSI (14)
45.3
Neutral
MACD (12,26,9)
0.09
Hist -0.06
ATR (14)
0.19
1.10% of price
Realised vol 30D
18.3%
Annualised
Bollinger upper
18.49
20, 2σ
Bollinger lower
17.27
20, 2σ
50 / 200 cross
Golden
17.69 vs 15.15
Trend bias
Above 200
+16.11%

Options chain

Account required
Expiry
Spot 17.59
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.61
Less volatile than market
Correlation to SPY
0.43
Loosely linked
Realised vol 30D
18.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-9.7%
Peak to trough
Max drawdown 5Y
-60.5%
Peak to trough
ATR 14
0.19
1.10% of price
Beta (reported)
—
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.